Cargando…
COVID-19 and Plasmodium vivax malaria co-infection
The ongoing outbreak of COVID-19 poses an unprecedented global health challenge. With its variety of clinical manifestations including, but not limited to, fever, cough, diarrhea, vomiting, headache, myalgia and fatigue, it may be challenging to distinguish COVID-19 from a spectrum of diseases with...
Autores principales: | Sardar, Sundus, Sharma, Rohit, Alyamani, Tariq Yousef Mohammad, Aboukamar, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305490/ https://www.ncbi.nlm.nih.gov/pubmed/32665888 http://dx.doi.org/10.1016/j.idcr.2020.e00879 |
Ejemplares similares
-
Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021) -
Plasmodium vivax Malaria
por: Kochar, Dhanpat K., et al.
Publicado: (2005) -
Plasmodium vivax Malaria in Cambodia
por: Siv, Sovannaroth, et al.
Publicado: (2016) -
Co-Infection with Plasmodium vivax and COVID-19 in Thailand
por: Boonyarangka, Parat, et al.
Publicado: (2022) -
Epidemiology of Plasmodium vivax Malaria Infection in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2018)